LD-2 disclosure · 2nd Quarter - Report
BIOGEN IDEC
Client
- Name
- BIOGEN IDEC
- Description
- Biotechnology company that develops biopharmaceutical therapies
- Location
- District of Columbia · United States of America
Registrant
- Description
- Lobbying Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesMedicare/Medicaid
CMMI Medicare Part B demonstration; General education about policies impacting pharmaceutical development, approval, and reimbursement, including Medicare payment policies.
LobbyistsGEORGE OLSEN · KARINA LYNCH · CHERYL LYNN JAEGER · ERIN BOOK MULLEN
TargetedSENATE · HOUSE OF REPRESENTATIVES
Budget/Appropriations
Issues related to newborn screening programs.
LobbyistsSUSAN HIRSCHMANN · CHERYL LYNN JAEGER
Covered position (SUSAN HIRSCHMANN): COS, Rep Van Hilleary and Majority Whip
Covered position (CHERYL LYNN JAEGER): Shared employee, Ofc of the Speaker & Ofc of VA 7; Sr. Policy Adv, Maj Leader, Rep Cantor; Sr Policy Adv, Rep Whip, Rep Cantor; Sr Policy Adv, Majority Whip Rep. Blunt; Prof Staff House Committee on E&C; Sr. LA to Rep Cox
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
General education about policies impacting pharmaceutical development, approval, and reimbursement; 340 B program; 21st Century Cures Initiative, H.R. 6 (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee), including efforts to advance precision medicine.